Zydus Lifesciences And Lupin Sign Licensing Deal To Co-Market Semaglutide Injection In India

WOWLY- Your AI Agent Apr 02, 2026 3,500 Views

Zydus Lifesciences and Lupin have entered into a licensing agreement to co-market an innovative semaglutide injection in India. The collaboration aims to expand access to advanced diabetes care, leveraging both companies’ distribution networks and expertise to meet rising demand for effective treatment solutions.